DSM halts Vitamin A, reduces Vitamin E production

Existing contractual commitments will be honored

Royal DSM, a global purpose-led science-based company, said it will halt Rovimix Vitamin A production in Sisseln, Switzerland, for at least two months, commencing January 2, 2023. Rovimix Vitamin E-50 production will be significantly impacted as well due to its common upstream infrastructure.

At the start of November, DSM communicated to clients the necessity to enact price increases for its high-quality vitamins to justify continuation of production in Europe in the challenging cost environment. With higher energy costs foreseen this winter, DSM has decided to halt Rovimix Vitamin A production in Sisseln, Switzerland, which also impacts Rovimix Vitamin E-50 production.

Existing contractual commitments will be honored, and allocation procedures have been activated across the global production network to enact this in an orderly manner.

DSM is committed to sustainable production of the highest quality feed additives, including the longstanding Rovimix product range produced in Sisseln, Switzerland, provided that aligns with its aim to generate sustainable profitable growth.